CoChat

Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence

Open access
Rehman, Khalid, Lötsch, Felix, Kremsner, Peter G., Ramharter, Michael · 2014 · International Journal of Infectious Diseases
Cited by 97

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Artemisinin derivatives are the mainstay of antimalarial treatment, both for uncomplicated malaria and for severe disease. Artemisinins are known for their rapid onset of action, good tolerability, and safety. However, besides the sporadic but worrying reports of delayed parasite clearance after treatment with artemisinins, there have been an increasing number of reports of acute haemolytic anaemia following their use and the safety of this class of antimalarials is being questioned. METHODS: In this systematic review, all reports of patients experiencing haemolysis following the use of artemisinins for the treatment of malaria were identified and collated into an electronic database. Summary statistics were calculated to characterize the epidemiology and clinical features of this safety concern related to artemisinin derivatives. RESULTS: A total of 37 patients were identified suffering from haemolysis following the treatment of severe malaria with artemisinin derivatives. Thirty-one cases had received intravenous artesunate, while the remaining cases were attributed to other parenteral or oral regimens of artemisinin derivatives. The majority of patients were returning travellers (n=30), and six clinical cases had been reported in paediatric patients. The median onset of haemolysis was 15 (interquartile range (IQR) 13-15) days after the initiation of treatment for the 'delayed-onset' pattern and 17 (IQR 13-22) days for the 'persistent' haemolysis pattern. The median reduction in haemoglobin due to haemolysis was 6 g/dl (IQR 4-8 g/dl). The estimated proportion of patients suffering from severe malaria experiencing haemolysis after treatment with artemisinin derivatives was 13% (95% confidence interval 9-18%), and 73% of these (i.e., 9% of the total population) required blood transfusions. No fatal outcome has been reported in the literature to date. CONCLUSIONS: Haemolysis is commonly associated with the class of artemisinin drugs when used for the treatment of severe malaria. Potential causes of this safety issue are discussed. Although no deaths attributed to haemolysis have been reported so far, this safety issue may lead to life-threatening anaemia and is particularly worrying for regions where safe blood products are not readily available.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ijid.2014.09.007

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 27

  1. Auer-Hackenberg, 2012, Automated red blood cell exchange as an adjunctive treatment for severe Plasmodium falciparum malaria at the Vienna General Hospital in Austria: a retrospective cohort study, Malaria J, 11, 158, 10.1186/1475-2875-11-158 · DOI
  2. Ramharter, 2004, In vitro activity of quinolines against Plasmodium falciparum in Gabon, Acta Trop, 90, 55, 10.1016/j.actatropica.2003.11.001 · DOI
  3. Sinclair, 2009, Artemisinin-based combination therapy for treating uncomplicated malaria, Cochrane Database Syst Rev, CD007483
  4. Verdrager, 1999, Averting a malaria disaster, Lancet, 354, 1389, 10.1016/S0140-6736(05)76245-0 · doi:10.1016/s0140-6736(05)76245-0
  5. Askling, 2012, Management of imported malaria in Europe, Malar J, 11, 328, 10.1186/1475-2875-11-328 · DOI
  6. Kremsner, 2004, Antimalarial combinations, Lancet, 364, 285, 10.1016/S0140-6736(04)16680-4 · DOI · Paper page
  7. Dondorp, 2010, Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial, Lancet, 376, 1647, 10.1016/S0140-6736(10)61924-1 · DOI · Paper page
  8. Rolling, 2012, Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia, Malaria J, 11, 169, 10.1186/1475-2875-11-169 · DOI
  9. Rolling, 2013, Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis, Malar J, 12, 241, 10.1186/1475-2875-12-241 · DOI
  10. Eder, 2012, Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre, Pathog Glob Health, 106, 181, 10.1179/2047773212Y.0000000032 · DOI
  11. Kano, 2010, Artemisinin-based combination therapies and their introduction in Japan, J Infect Chemother, 16, 375, 10.1007/s10156-010-0077-1 · DOI
  12. Caramello, 2012, Severe malaria, artesunate and haemolysis, J Antimicrob Chemother, 67, 2053, 10.1093/jac/dks139 · DOI
  13. Zoller, 2011, Intravenous artesunate for severe malaria in travelers, Europe, Emerg Infect Dis, 17, 771, 10.3201/eid1705.101229 · DOI
  14. Kreeftmeijer-Vegter, 2012, Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium, Malar J, 11, 102, 10.1186/1475-2875-11-102 · DOI
  15. Rolling, 2014, Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria—a double-center prospective study, J Infect Dis, 209, 1921, 10.1093/infdis/jit841 · DOI
  16. World Health Organization, 2000, Communicable Disease Cluster, Geneva, Switzerland. Severe falciparum malaria definition, Trans R Soc Trop Med Hyg, 94, S1, 10.1016/S0035-9203(00)90300-6 · DOI · Paper page
  17. Jarvis, 2013, Artemisinin therapy and severe delayed haemolysis, Lancet, 382, 180, 10.1016/S0140-6736(13)60812-0 · DOI
  18. Rouya, 2013, A case of hemolytic anemia after severe malaria successfully treated with artesunate. Joined Symposium belgische vereniging voor infectiologie en klinische microbiologie, Scientific Study Group for Travel Medicine
  19. De Nardo, 2013, Haemolytic anaemia after oral artemether–lumefantrine treatment in a patient affected by severe imported falciparum malaria, Infection, 41, 863, 10.1007/s15010-013-0451-x · doi:10.1007/s15010-013-0451-x
  20. Corpolongo, 2012, Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether–lumefantrine, Malar J, 11, 91, 10.1186/1475-2875-11-91 · DOI
  21. Kremsner, 2012, A simplified intravenous artesunate regimen for severe malaria, J Infect Dis, 205, 312, 10.1093/infdis/jir724 · DOI
  22. Cramer, 2011, Treatment of imported severe malaria with artesunate instead of quinine—more evidence needed?, Malar J, 10, 256, 10.1186/1475-2875-10-256 · DOI
  23. Chotivanich, 2002, Central role of the spleen in malaria parasite clearance, J Infect Dis, 185, 1538, 10.1086/340213 · DOI · Paper page
  24. Angus, 1997, In vivo removal of malaria parasites from red blood cells without their destruction in acute falciparum malaria, Blood, 90, 2037, 10.1182/blood.V90.5.2037 · DOI
  25. Del Portillo, 2012, The role of the spleen in malaria, Cell Microbiol, 14, 343, 10.1111/j.1462-5822.2011.01741.x · DOI · Paper page
  26. Ramharter, 2008, Fixed-dose pyronaridine–artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon, J Infect Dis, 198, 911, 10.1086/591096 · DOI
  27. Ramharter, 2007, Pharmacokinetics of two paediatric artesunate–mefloquine drug formulations in the treatment of uncomplicated falciparum malaria in Gabon, J Antimicrob Chemother, 60, 1091, 10.1093/jac/dkm355 · DOI

Cited by

See all 97

Metadata

Authors
Rehman, K., Lötsch, F., Kremsner, P. G., & Ramharter, M.
Venue
International Journal of Infectious Diseases
Publisher
Elsevier BV
Published
2014-12
Volume
29
Pages
268-273
ISSN
1201-9712 (ISSN-L)
OpenAlex
W2038101188
Cited by
97
References
1
FWCI
1.65
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence. https://app.cochat.ai/papers/10.1016/j.ijid.2014.09.007
The paper
Rehman, K., Lötsch, F., Kremsner, P. G., & Ramharter, M. (2014). Haemolysis associated with the treatment of malaria with artemisinin derivatives: a systematic review of current evidence. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2014.09.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.